These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36795582)

  • 1. Reported History of Measles and Long-term Impact on Tetanus Antibody Detected in Children 9-59 Months of Age and Receiving 3 Doses of Tetanus Vaccine in the Democratic Republic of the Congo.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Mukadi P; Higgins SG; Budd R; Randall C; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Wells C; Rimoin AW
    Pediatr Infect Dis J; 2023 Apr; 42(4):338-345. PubMed ID: 36795582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Higgins SG; Budd R; Randall C; Mwamba GN; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Rimoin AW
    Vaccine; 2020 Feb; 38(9):2258-2265. PubMed ID: 32057333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013-2014.
    Cheng A; Ghanem-Uzqueda A; Hoff NA; Ashbaugh H; Doshi RH; Mukadi P; Budd R; Higgins SG; Randall C; Gerber S; Kabamba M; Ngoie Mwamba G; Okitolonda-Wemakoy E; Muyembe-Tanfum JJ; Rimoin AW
    PLoS One; 2022; 17(5):e0268703. PubMed ID: 35587922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Previous Measles Infection With Markers of Acute Infectious Disease Among 9- to 59-Month-Old Children in the Democratic Republic of the Congo.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Higgins SG; Budd R; Randall C; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Rimoin AW
    J Pediatric Infect Dis Soc; 2019 Dec; 8(6):531-538. PubMed ID: 30346573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of measles vaccine effectiveness among children in the Democratic Republic of Congo.
    Doshi RH; Mukadi P; Shidi C; Mulumba A; Hoff NA; Gerber S; Okitolonda-Wemakoy E; Ilunga BK; Muyembe JJ; Rimoin AW
    Vaccine; 2015 Jun; 33(29):3407-14. PubMed ID: 25937449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo.
    Ashbaugh HR; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Cherry JD; Rimoin AW
    Vaccine; 2018 Jan; 36(4):587-593. PubMed ID: 29248265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme.
    Warrener L; Bwogi J; Andrews N; Samuel D; Kabaliisa T; Bukenya H; Brown K; Roper MH; Featherstone DA; Brown D
    Epidemiol Infect; 2018 Jul; 146(9):1151-1156. PubMed ID: 29739482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.
    Farquhar C; Wamalwa D; Selig S; John-Stewart G; Mabuka J; Majiwa M; Sutton W; Haigwood N; Wariua G; Lohman-Payne B
    Pediatr Infect Dis J; 2009 Apr; 28(4):295-9. PubMed ID: 19258919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
    Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
    BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.
    Knipes AK; Summers A; Sklavounos AA; Lamanna J; de Campos RPS; Narahari T; Dixon C; Fobel R; Ndjakani YD; Lubula L; Magazani A; Muyembe JJ; Lay Y; Pukuta E; Waku-Kouomou D; Hao L; Kayembe JK; Fobel C; Dahmer J; Lee A; Ho M; Valenzuela JGC; Rackus DG; Shih R; Seale B; Chang A; Paluku G; Rota PA; Wheeler AR; Scobie HM
    PLoS One; 2022; 17(12):e0278749. PubMed ID: 36542608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunization considerations in pediatric patients with malignancy and chronic immune thrombocytopenic purpura.
    Abdolkarimi B; Amanati A; Molavi Vardanjani H; Jamshidi S; Tabaeian SAP
    BMC Infect Dis; 2022 Jul; 22(1):657. PubMed ID: 35902837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study.
    Ingelman-Sundberg HM; Laestadius Å; Chrapkowska C; Mördrup K; Magnusson B; Sundberg E; Nilsson A
    Vaccine; 2016 Mar; 34(10):1304-11. PubMed ID: 26827664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey.
    Yildirim RC; Yilmaz N; Yildirim U; Aksakal FN
    Am J Infect Control; 2001 Apr; 29(2):120-3. PubMed ID: 11287881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
    Acharya P; Kismul H; Mapatano MA; Hatløy A
    PLoS One; 2018; 13(8):e0202742. PubMed ID: 30138459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Mumps Infection Among Children in the Democratic Republic of Congo.
    Doshi RH; Alfonso VH; Hoff NA; Mukadi P; Gerber S; Bwaka A; Higgins SG; Mwamba GN; Okitolonda E; Muyembe JJ; Rimoin AW
    Pediatr Infect Dis J; 2017 May; 36(5):462-466. PubMed ID: 28002360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots.
    Higgins SG; Hoff NA; Gadoth A; Fusellier A; Mukadi P; Alfonso V; Randall C; Ashbaugh H; Poncheri M; Doshi RH; Gerber S; Budd R; Wolfert R; Williams R; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31413172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative tetanus antibody response of Nigerian children to diphtheria-pertussis-tetanus and pentavalent vaccines.
    Uket HO; Ekanem EE; Okpara HC; Ekrikpo UE
    Niger Postgrad Med J; 2018; 25(3):137-142. PubMed ID: 30264763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.